Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 18422.76 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 2868.39 Crore, up 2.37 % from last quarter Total Income of Rs 2801.85 Crore and up 2.02 % from last year same quarter Total Income of Rs 2811.63 Crore. Company reported net profit after tax of Rs 233.87 Crore in latest quarter.
Investment Rationale
A decisive breakthrough above the recent high could shift the range on the upside.
Promoter/FII Holdings
Promoters held 46.6 per cent stake in the company as of Dec 30, 2020, while FIIs held 30.2 per cent, DIIs 7 per cent and public and others 16.2 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
